StockData

Sangrix vs Sentage

SGRX and SNTG side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SGRX and SNTG compare

Sentage scores higher on the StockData Score (6 against 5 for Sangrix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSGRXSNTG
Size and price
Share price$2.56$1.72
Change, 1 year−99.6%−14.4%
Change, 5 years−100.0%−80.4%
Beta (5Y)1.401.15
Employees11
StockData Score
Total score56 (better)
Valuation score00
Growth score00
Performance score01 (better)
Health score55
Dividend score00
Growth
Revenue growth (TTM)–−35.9%
Revenue growth, 5Y average–−54.7%
Profitability
Gross margin–91.2%
Operating margin–−3301%
Net margin–−3305%
Return on equity–−25.2%
Return on invested capital−286%−22.0% (better)
Financial health
Debt / equity0.000.00
Current ratio6.98 (better)2.14
Piotroski F-score–3
Ownership
Held by insiders–62.2%
Short interest, % of float–0.73%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.